Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.

Experimental lung research - 1 Jan 2000

Tan Shanjuan, Sun Changqing, Wei Xiaoling, Li Yanqiang, Wu Yongjun, Yan Zhen, Feng Feifei, Wang Jing, Wu Yiming

Abstract excerpt

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths worldwide due mainly to late diagnosis and poor prognosis. Aberrant promoter methylation is an important mechanism for silencing of tumor suppressor genes during carcinogenesis and a promising tool for the development of molecular biomarkers. METHODS: We evaluated the p16, RASSF1A, and FHIT genes promoter methylation status in peripheral blood...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acid Anhydride Hydrolases
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to DNA Methylation

Share to Logistic Models

Share to Neoplasm Proteins

Share to Risk Assessment

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 23614702
DOI: 10.3109/01902148.2013.790096

Genes

FHIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.PMID 23614702Read ↗

Quantitative promoter hypermethylation analysis of RASSF1A in lung cancer: comparison with methylation-specific PCR technique and clinical significance.Semantic proximity Read ↗

DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNASemantic proximity Read ↗

Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers.Semantic proximity Read ↗

Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasmaSemantic proximity Read ↗

Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors.Semantic proximity Read ↗

Identification of Epigenetic Aberrant Promoter Methylation in Serum DNA Is Useful for Early Detection of Lung CancerSemantic proximity Read ↗

Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer RiskSemantic proximity Read ↗

Genome-wide analysis of DNA methylation in bronchial washingsSemantic proximity Read ↗

Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer.Semantic proximity Read ↗

DNA methylation in pulmonary fibrosis and lung cancerSemantic proximity Read ↗

A Panel of DNA Methylation Biomarkers for Detection and Improving Diagnostic Efficiency of Lung CancerSemantic proximity Read ↗

Association of RASSF1A promoter methylation with lung cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.